ELMD · XBRL financial data

Electromed financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (ELMD's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Revenue	35,756	41,659	48,067	54,716	—	—
Revenue from contracts with customers	35,756	41,659	48,067	54,716	64,000	73,776
Cost of revenue	8,451	10,217	11,548	12,990	14,029	15,833
Gross profit	27,305	31,442	36,519	41,726	49,971	57,943
Research and development	1,722	1,356	916	656	996	1,314
Selling, general and administrative	22,443	27,114	31,595	34,489	39,315	42,748
Total operating expenses	24,165	28,470	32,511	35,145	40,311	44,062
Operating income (loss)	3,140	2,972	4,008	6,581	9,660	13,881
Income tax expense (benefit)	805	692	920	1,886	2,747	3,059
Net income (loss)	2,362	2,305	3,166	5,150	7,537	11,301
Earnings per share, basic USD per share	0.28	0.27	0.37	0.60	0.89	1.37
Earnings per share, diluted USD per share	0.27	0.26	0.36	0.58	0.85	1.30
Weighted average shares, basic thousands of shares	8,566	8,471	8,464	8,562	8,454	8,266
Weighted average shares, diluted thousands of shares	8,912	8,769	8,701	8,865	8,914	8,689

Fiscal years (ELMD's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Cash and cash equivalents	11,889	8,153	7,372	16,080	15,287	20,450
Accounts receivable	17,032	21,052	24,130	23,333	24,660	29,805
Inventory	2,114	3,178	4,221	3,712	3,299	3,681
Prepaid and other current assets	276	1,870	1,577	329	392	1,170
Total current assets	31,704	34,539	37,787	44,173	45,082	57,368
Property and equipment, net	3,605	4,568	5,672	5,165	4,714	5,214
Right-of-use asset	88	120	—	87	198	131
Total assets	37,109	41,364	45,806	52,234	53,802	66,267
Accounts payable	685	1,261	1,372	1,010	2,667	2,643
Current portion of long-term debt	33	—	—	—	—	—
Total current liabilities	4,639	7,150	8,053	7,677	10,468	12,222
Total liabilities	4,693	7,191	8,139	7,689	10,593	12,288
Retained earnings	14,922	15,780	18,793	23,668	21,185	28,564
Total stockholders' equity	32,416	34,173	37,667	44,545	43,209	53,979
Total liabilities and equity	37,109	41,364	45,806	52,234	53,802	66,267
Common shares outstanding (cover page) thousands of shares	8,589	8,475	8,555	8,639	8,349	8,366

Fiscal years (ELMD's year ends in late June)

In thousands of dollars	FY 2021Jun 30, 2021	FY 2022Jun 30, 2022	FY 2023Jun 30, 2023	FY 2024Jun 30, 2024	FY 2025Jun 30, 2025	FY 2026Jun 30, 2026
Net income (loss)	2,362	2,305	3,166	5,150	7,537	11,301
Stock-based compensation	1,024	976	708	1,692	3,059	2,722
Net cash from operating activities	3,077	(686)	1,315	9,067	11,393	9,665
Purchases of property and equipment	287	1,425	1,648	287	262	1,252
Net cash from investing activities	(448)	(1,525)	(1,716)	(395)	(306)	(1,300)
Share repurchases	1,124	1,448	153	275	10,000	3,918
Net cash from financing activities	(1,219)	(1,525)	(380)	36	(11,880)	(3,202)
Net change in cash	1,410	(3,736)	(781)	8,708	(793)	5,163

SIC 3845 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 3845 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
Runway shows only for companies burning cash with under $10B of public float.
* marks a quarter worked out from the filing totals: for a 10-K, the year less the first three quarters; for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($K)	Revenue, quarter ($K)	Operating cash flow, quarter ($K)	Shares outstanding	Runway	Quarter
Electromed	20,450	19,417*	2,994*	8.4M	—	Q4 FY26 10-KJun 30, 2026
Tactile Systems Technology	75,110	91,858	11,978*	22.4M	—	Q3 FY26 10-QSep 30, 2026
Orasure Technologies	160,582	30,639	(9,921)*	69.0M	16.2 quarters	Q2 FY26 10-QJun 30, 2026
Cerus	16,350	57,714	3,007*	202.0M	—	Q3 FY26 10-QSep 30, 2026
SANUWAVE Health	9,376	9,739	425*	8.6M	—	Q2 FY26 10-QJun 30, 2026
Inogen	87,276	95,084	2,946*	26.5M	—	Q2 FY26 10-QJun 30, 2026
Bioventus	30,709	142,442	20,658*	not reported	—	Q3 FY26 10-QSep 26, 2026
Treace Medical Concepts	12,610	45,376	(4,698)*	65.0M	9.7 quarters	Q2 FY26 10-QJun 30, 2026
SS Innovations International	13,647	not reported	(4,235)*	200.4M	3.2 quarters	Q2 FY26 10-QJun 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.